Unfortunately that is all we have so that is reality. The misconception that most have is that this is an actual pharmaceutical company and that it is structured as such. It is NOT! That ended in 2018 when Chris Lowe shut the operational functions of the company down for lack of funds. Since then and I believe it will continue as a entity that relies on others to carry on investigative work and/or research on its IP and Patents and at the same time it pursues agreements to license, partner or sell those IP and patents outright or the entire company. As this structure it does not need an office or lab or employees or any of the envisioned attributes that most think would be incorporated in an actual pharma co. It has morphed into a broker co not dissimilar to your neighborhood realtor.